GlaxoSmithKline Halts Production of Poligrip – Zinc Side Effects Lawsuits

GlaxoSmithKline, London-based maker of popular denture cream Poligrip, has announced that it will voluntarily halt production of the zinc-containing denture cream following several class action lawsuits. The lawsuits claim that Glaxo failed to inform consumers of potential health risks associated with high amounts of zinc over a long period of time. Plaintiffs claim that long-term use of Poligrip has led to devastating personal injuries, including loss of balance, loss of sensation in the hands and feet, and anemia.

According to a recent study, researchers concluded that high doses of zinc lead to depletion of copper in the human body, which can cause damage to the brain and central nervous system.

Meanwhile, Glaxo announced it is voluntarily ceasing production and marketing efforts of Super Poligrip Original, Ultra Fresh and Extra Care products, with plans to reformulate the creams in the near future. However, the company upholds that the products are safe when used as directed. The company claims that some people use too much cream to correct ill-fitting dentures, essentially putting themselves at risk of overexposure.

Although proven to be harmful in high doses – according to the Consumer Healthcare Products Association – the FDA has never issued a safety warning since it first approved creams containing zinc more than 15 years ago.

If you believe you or a loved one has been injured following long-term use of Poligrip or any of the above-named products associated with neurological damage and blood disorders, please contact AWKO law today at (888) 255 – 2956. You may be eligible to receive substantial compensation from the manufacturer for your pain and suffering.